Wheezing in Young Children: Oral Prednisolone Study

We are investigating whether oral prednisolone helps children under 2 years old with wheezing caused by rhinovirus. This study aims to find out if it improves their breathing and overall comfort.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Prednisolone Sodium Phosphate
Prednisolone sodium phosphate is a corticosteroid that reduces inflammation and suppresses the immune system for allergic and inflammatory conditions.
Sucrose
Sucrose is a common sugar used as a sweetener and a quick source of energy.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Keski-Pohjanmaan hyvinvointialue
Paediatric emergency clinic
Kokkola, Finland
Oulu University Hospital
Paediatric and Youth Emergency Clinic
Oulu, Finland
Sponsor: University Of Oulu
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.